Cystadrops® (cysteamine) – New drug approval
August 19, 2020 - The FDA approved Recordati Rare Diseases’ Cystadrops (cysteamine) topical ophthalmic solution for the treatment of corneal cystine crystal deposits in adults and children with cystinosis.
Download PDF
